Chronic intestinal inflammation in IBD triggers cellular senescence, which accumulates and secretes factors that drive aberrant blood vessel formation, tissue hypoxia, and progression toward colorectal cancer. Targeting the senescence-angiogenesis axis offers a mechanistic pathway for early intervention and cancer prevention in IBD patients.
Key Points
- Senescent cells in IBD secrete pro-angiogenic factors driving vascular dysfunction
- Tissue hypoxia and immune suppression reinforce inflammation and genomic instability
- Senescent cell heterogeneity suggests distinct interventions for cancer prevention
Longevity Analysis
This research identifies a specific mechanism by which chronic inflammation reshapes the tissue microenvironment to accelerate disease progression. The senescence-angiogenesis pathway represents a critical window where intervention can interrupt the cascade from inflammatory disease to malignancy. Understanding how cellular aging propagates through secretory signaling—rather than treating inflammation as a monolithic process—allows for more precise therapeutic targeting. For individuals with IBD or chronic inflammatory conditions, this work shifts focus from symptom suppression alone toward addressing the underlying cellular dysfunction that permits cancer development.
Original published by Wiley Aging Cell, by Ruoshu Duan, Qingyu Chen, Yuan Xu, Ye Yan, Sujing Jiang .